News

Olympia Pharmaceuticals | 503B Outsourcer | 503A Compounding Pharmacy

Market 50/100How we got 50/100Source tierUnclassified sourceTier ceiling50/100Independent sourcesnot recordedPublished score50/100Scored at the ceiling for a unclassified source source — it cannot go higher. The number is the source page’s own score, hard-capped at the tier ceiling; corroboration is recorded but cannot lift a score past that cap. Under 40 a claim goes to review instead of publication. Full methodology →
July 28, 2026↗ source

Olympia Pharmaceuticals is promoting its services as a 503B FDA-registered outsourcing facility and affiliated 503A compounding pharmacy. The company highlights its ability to ship medications nationwide for office use and direct patient fulfillment, emphasizing quality control measures like sterility and potency testing. Their product catalog includes various injections used in weight management, longevity, and hormone therapies, often containing peptides popular in the wellness and anti-aging markets.

Related peptides

BPC-157TB-500GLP-1 receptor agonistsGlutathioneGLP-1LongevityPeptide TGLP-1 receptor agonistPeptide therapeuticsGLP-1R
We summarize, we don't invent — every detail here traces to a real, linked source, and the badge reflects how trustworthy that source is. Read the original and decide for yourself.